ABSTRACT
Con el surgimiento y el desarrollo de la cirugía refractiva corneal se han podido corregir quirúrgicamente a millones de pacientes con defectos refractivos. Con el cursar de los años comienza a opacarse fisiológicamente el cristalino, y disminuye la agudeza visual en estos pacientes a quienes se les modificó la curvatura corneal. Ante la necesidad de remover el cristalino y de calcular una lente intraocular de potencia adecuada para conseguir la emetropía, surge un nuevo reto a la Oftalmología. El cálculo de la lente intraocular en pacientes con cirugía refractiva corneal es mucho más complejo, pues además de tener longitudes axiales extremas, se añaden factores por la intervención previa que alteran la predictibilidad del resultado visual, con la aplicación de las fórmulas de cálculo de lente intraocular existentes. Se han descrito varios métodos que permiten determinar correctamente la potencia de la lente a implantar, dependiendo de los datos de los que se dispongan; de ahí la motivación para realizar una revisión de diferentes publicaciones con el propósito de describir los principales métodos empleados para realizar el cálculo de la lente intraocular en estos pacientes. Se utilizó la plataforma Infomed, específicamente la Biblioteca Virtual de Salud, con todos sus buscadores(AU)
With the emergence and development of the corneal refractive surgery, the refractive defects of millions of patients have been surgically corrected. As time goes by, the physiological opacification of the crystalline lens begins, thus reducing the visual acuity of those patients whose corneal curvature has been modified. Should the crystalline lens be modified and should the intraocular lens power be adequately calculated to achieve emetropia, ophthalmology faces then a new challenge. The intraocular lens calculation in patients with corneal refractive surgery is much more complex since, in addition to extreme axial lengths, there are factors derived from the previous surgery that alter predictability of the visual result, with the use of existing intraocular lens calculation formulae. Several methods have been so far described, which allow correctly determining the lens power to be implanted, depending on available data. This was the main reason for making a review of different publications to describe the main methods for intraocular lens calculation in these patients. Infomed platform, mainly the virtual library of health, was used with all its searchers(AU)
Subject(s)
Humans , Databases, Bibliographic/statistics & numerical data , Lens Implantation, Intraocular/methods , Orthokeratologic Procedures/methods , Refractive Surgical Procedures/methodsABSTRACT
PURPOSE: The purpose of this multi-institute, single-group clinical trial was to evaluate the effectiveness and safety of toric orthokeratology lenses for the treatment of patients with combined myopia and astigmatism. METHODS: A total of 44 patients were included in this clinical trial. The patients ranged in age from 7 to 49 years, with myopia of -0.75 to -6.0 diopters (D) and astigmatism of 1.25 to 4.0 D. After excluding 21 subjects, 23 subjects (39 eyes) were analyzed after toric orthokeratology lens use. The subjects underwent ophthalmologic examination after 1 day and 1, 2, 3, and 4 weeks of wearing overnight toric orthokeratology lenses. RESULTS: A total of 19 subjects (31 eyes) completed the trial after five subjects (eight eyes) dropped out. In the patients who completed the study by wearing lenses for 4 weeks, the myopic refractive error decreased significantly by 2.60 ± 2.21 D (p < 0.001), from -3.65 ± 1.62 to -1.05 ± 1.64 D. The astigmatic refractive error were also significantly decreased by 0.63 ± 0.98 D (p = 0.001), from 2.07 ± 0.83 to 1.44 ± 0.99 D. The mean uncorrected and corrected visual acuities before wearing the lenses were 2.14 ± 0.80 logarithm of the logMAR (logMAR) and 0.05 ± 0.13 logMAR, respectively, which changed to 0.12 ± 0.30 logarithm of the logMAR (p < 0.001) and 0.01 ± 0.04 logMAR (p = 0.156) after 4 weeks. No serious adverse reactions were reported during the clinical trial. CONCLUSIONS: Our results suggest that toric orthokeratology is an effective and safe treatment for correcting visual acuity in patients with combined myopia and astigmatism.